Convatec Group PLC
Convatec Group PLC scores highest on Nitro (64) and lowest on Price (23). Its PosiPenta is 39.93 out of 100, weaker than most similar companies.
On the Penta Grid this week, Convatec Group PLC is Grid #7 of 8 in the Healthcare sector in United Kingdom, and Grid #91 of 98 in United Kingdom.
Compared with similar companies in the Healthcare sector in United Kingdom.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Convatec Group PLC | 39.93 | 23 | 50 | 64 | 27 | 35 |
| Hikma Pharmaceuticals PLC | 62.00 | 77 | 61 | 61 | 50 | 61 |
| LivaNova PLC | 58.55 | 40 | 63 | 86 | 64 | 40 |
| Smith & Nephew plc | 43.29 | 52 | 55 | 17 | 46 | 46 |
| Roivant Sciences Ltd. | 38.43 | 9 | 11 | 68 | 52 | 52 |
| Haleon plc | 48.21 | 55 | 31 | 50 | 52 | 53 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 47.60 |
| P/B ratio | 3.99 |
EEarnings
| Trailing EPS | ₹6.33 |
| Forward EPS | ₹21.78 |
NNitro
| Price | 301.28 |
| 52-week high | 328.23 |
| 52-week low | 244.31 |
| Fall from 52-week high | 8.2% |
TTorque
| Return on equity (ROE) | 7.65% |
| Debt-to-equity | 1.22 |
AAnchor
| Beta (price swings) | 0.77 |
| Market cap | ₹57,598 Cr |
| Insider holding | 0.20% |
| Dividend yield | 2.33% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Convatec Group PLC's PosiPenta score?
Convatec Group PLC's PosiPenta is 39.93 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Convatec Group PLC stand on the Penta Grid?
On the Penta Grid this week, Convatec Group PLC is Grid #7 of 8 in the Healthcare sector in United Kingdom, and Grid #91 of 98 in United Kingdom.
Which PosiPenta pillar is strongest for Convatec Group PLC?
Nitro (momentum), with a score of 64 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Convatec Group PLC?
Price (valuation), with a score of 23 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.